Famon Awal Bros Sedaya Tbk PT
IDX:PRAY
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
600
715
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Famon Awal Bros Sedaya Tbk PT
Cost of Revenue
Famon Awal Bros Sedaya Tbk PT
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F
|
Famon Awal Bros Sedaya Tbk PT
IDX:PRAY
|
Cost of Revenue
-Rp1.3T
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Siloam International Hospitals Tbk PT
IDX:SILO
|
Cost of Revenue
-Rp7.2T
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-13%
|
|
|
Medikaloka Hermina Tbk PT
IDX:HEAL
|
Cost of Revenue
-Rp4.2T
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Metro Healthcare Indonesia Tbk PT
IDX:CARE
|
Cost of Revenue
-Rp153B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
|
Cost of Revenue
-Rp2T
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-24%
|
|
|
Mitra Keluarga Karyasehat Tbk PT
IDX:MIKA
|
Cost of Revenue
-Rp2.2T
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-8%
|
|
Famon Awal Bros Sedaya Tbk PT
Glance View
PT Famon Awal Bros Sedaya Tbk operates as a holding company with interest in hospital operation. The company is headquartered in Jakarta Pusat, Dki Jakarta and currently employs 5,157 full-time employees. The company went IPO on 2022-11-08. The firm is engaged in private hospital activities and other management consulting. The firm operates approximately 15 hospitals across various cities in Indonesia. Its geographical segments include Jawa, Kalimantan dan and Sulawesi, and Sumatera. The Company’s subsidiaries include PT Famon Global Medika, PT Fortuna Anugerah Sehat, PT Fortuna Anugerah Medika, PT Fortuna Graha Sentosa, PT Fortuna Medika Sejahtera, PT Fortuna Prima Sentosa, PT Fortuna Sentosa Sejahtera, PT Fortuna Griya Medika, PT Fortuna Selamat Sejahtera, PT Global Prime System and PT Kasih Karunia Alkesindo, and others.
See Also
What is Famon Awal Bros Sedaya Tbk PT's Cost of Revenue?
Cost of Revenue
-1.3T
IDR
Based on the financial report for Dec 31, 2023, Famon Awal Bros Sedaya Tbk PT's Cost of Revenue amounts to -1.3T IDR.
What is Famon Awal Bros Sedaya Tbk PT's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-19%
Over the last year, the Cost of Revenue growth was -16%. The average annual Cost of Revenue growth rates for Famon Awal Bros Sedaya Tbk PT have been -19% over the past three years .
You don't have any saved screeners yet
